
|Articles|August 28, 2019
ASRS 2019 Street Team: Rishi P. Singh, MD
Author(s)OT Staff Reports
ICYMI: Dr. Singh shares the take-home message from his 2019 presentation
Advertisement
Rishi P. Singh, MD, shares the take-home message of his presentation, “Sustained Diabetic Retinopathy Severity Improvement With Intravitreal Aflibercept in Diabetic Macular Edema: Post Hoc Analysis of VISTA and VIVID." Dr. Singh presented at the 2019 annual meeting of the American Society of Retina Specialists.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
Altered ipRGC circuits and function may translate to disrupted sleep and circadian rhythms in Alzheimer’s disease
2
StemSight gains patent for off-the-shelf limbal stem cell platform patent milestone for STE-101
3
CTS 2026: OTX-TKI demonstrates superiority over aflibercept in wet AMD—what the SOL-1 data mean for retina practice
4
Ranluspec FDA approval: Cyrus Karkaria, PhD, on biosimilar access, prefilled syringes, and long-term switching confidence
5




















